tiprankstipranks
Mirum Pharmaceuticals (MIRM)
:MIRM
US Market
Holding MIRM?
Track your performance easily

Mirum Pharmaceuticals (MIRM) Ownership - Who Owns Mirum Pharmaceuticals?

668 Followers

Mirum Pharmaceuticals (MIRM) Ownership Overview

9.63%26.24%0.31%12.40%51.41%
0.31% Other Institutional Investors
12.40% ETFs
51.41% Public Companies and Individual Investors
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 38.95% of the company’s stock is owned by Institutional Investors, 9.63% is owned by Insiders, and 51.41% is owned by Public Companies and Individual Investors.
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 26.55% of the company’s stock is owned by Institutional Investors, 9.63% is owned by Insiders, and 12.40% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 08, 2025
Peter Radovich
President & Coo
xxxxxxxxxxxxx
$85534
Jan 08, 2025
Christopher Peetz
Ceo,director
xxxxxxxxxxxxx
$320604
Nov 15, 2024
Jolanda Howe
Svp, Global Controller
xxxxxxxxxxxxx
$117750
Sep 20, 2024
Patrick Heron
Director, >10% Owner
xxxxxxxxxxxxx
$4301

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$7410000
Sep 30, 2024
xxxxxxxxxxxxx
$12909195

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,729,220Insider7.77%172,774,763
3,482,416Institution7.25%161,340,333
2,370,694Institution4.94%109,834,253
2,022,070Institution4.21%93,682,503
1,996,358Institution4.16%92,491,266
1,920,755Institution4.00%88,988,579
768,367Institution1.60%35,598,443
652,011Institution1.36%30,207,670
648,193Institution1.35%30,030,782
581,632Institution1.21%26,947,011

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,482,416Institution7.25%161,340,333
2,022,070Institution4.21%93,682,503
1,996,358Institution4.16%92,491,266
768,367Institution1.60%35,598,443
652,011Institution1.36%30,207,670
648,193Institution1.35%30,030,782
427,538Institution0.89%19,807,836
406,974Institution0.85%18,855,105
320,574Institution0.67%14,852,193
270,400Institution0.56%12,527,632

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,417,570Institution2.95%65,520,085
1,052,321Institution2.19%48,754,032
592,415Institution1.23%27,381,421
503,635Institution1.05%21,817,468
363,118Institution0.76%16,823,257
244,605Institution0.51%11,332,550
195,080Institution0.41%8,450,866
184,746Institution0.38%8,538,960
118,203Institution0.25%5,463,343
92,464Institution0.19%4,283,857

FAQ

Who Owns Mirum Pharmaceuticals (MIRM)?
According to the latest TipRanks data, approximately 0.31% of the company's stock is held by institutional investors, 9.63% is held by insiders, and 51.41% is held by retail investors.
    What percentage of Mirum Pharmaceuticals (MIRM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.31% of Mirum Pharmaceuticals (MIRM) stock is held by institutional investors.
      What percentage of Mirum Pharmaceuticals (MIRM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 51.41% of Mirum Pharmaceuticals (MIRM) stock is held by retail investors.
        Who owns the most shares of Mirum Pharmaceuticals (MIRM)?
        Patrick Heron owns the most shares of Mirum Pharmaceuticals (MIRM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis